Form 4: ICU Medical Inc. Executive Virginia Sanzone Sells Shares Under 10b5-1 Trading Plan

Virginia Sanzone, VP and General Counsel of ICU Medical Inc., sold 2,050 shares of common stock at a weighted average price of $144.1102 on August 8, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On August 8, 2024, Virginia Sanzone, the VP and General Counsel of ICU Medical Inc., sold 2,050 shares of the company's common stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on August 14, 2023.
• The shares were sold at a weighted average price of $144.1102.
• Following the transaction, Sanzone directly owns 4,482 shares of ICU Medical Inc.
• The price range for the sales was between $143.48 and $145.00.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance. The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on insider information.

Stakeholder Impact

• The stock sale by an executive could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates